rs28675771

Positions:

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000283.4(PDE6B):​c.*12A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.636 in 1,610,026 control chromosomes in the GnomAD database, including 329,275 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.58 ( 26789 hom., cov: 34)
Exomes 𝑓: 0.64 ( 302486 hom. )

Consequence

PDE6B
NM_000283.4 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -2.47
Variant links:
Genes affected
PDE6B (HGNC:8786): (phosphodiesterase 6B) Photon absorption triggers a signaling cascade in rod photoreceptors that activates cGMP phosphodiesterase (PDE), resulting in the rapid hydrolysis of cGMP, closure of cGMP-gated cation channels, and hyperpolarization of the cell. PDE is a peripheral membrane heterotrimeric enzyme made up of alpha, beta, and gamma subunits. This gene encodes the beta subunit. Mutations in this gene result in retinitis pigmentosa and autosomal dominant congenital stationary night blindness. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Feb 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 4-670119-A-G is Benign according to our data. Variant chr4-670119-A-G is described in ClinVar as [Benign]. Clinvar id is 349400.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr4-670119-A-G is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.654 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
PDE6BNM_000283.4 linkuse as main transcriptc.*12A>G 3_prime_UTR_variant 22/22 ENST00000496514.6

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
PDE6BENST00000496514.6 linkuse as main transcriptc.*12A>G 3_prime_UTR_variant 22/221 NM_000283.4 P3P35913-1

Frequencies

GnomAD3 genomes
AF:
0.585
AC:
88823
AN:
151942
Hom.:
26767
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.446
Gnomad AMI
AF:
0.768
Gnomad AMR
AF:
0.597
Gnomad ASJ
AF:
0.530
Gnomad EAS
AF:
0.445
Gnomad SAS
AF:
0.639
Gnomad FIN
AF:
0.679
Gnomad MID
AF:
0.566
Gnomad NFE
AF:
0.659
Gnomad OTH
AF:
0.575
GnomAD3 exomes
AF:
0.615
AC:
154433
AN:
251034
Hom.:
48351
AF XY:
0.621
AC XY:
84320
AN XY:
135740
show subpopulations
Gnomad AFR exome
AF:
0.441
Gnomad AMR exome
AF:
0.617
Gnomad ASJ exome
AF:
0.535
Gnomad EAS exome
AF:
0.426
Gnomad SAS exome
AF:
0.647
Gnomad FIN exome
AF:
0.678
Gnomad NFE exome
AF:
0.656
Gnomad OTH exome
AF:
0.624
GnomAD4 exome
AF:
0.641
AC:
935064
AN:
1457966
Hom.:
302486
Cov.:
33
AF XY:
0.643
AC XY:
466429
AN XY:
725460
show subpopulations
Gnomad4 AFR exome
AF:
0.433
Gnomad4 AMR exome
AF:
0.617
Gnomad4 ASJ exome
AF:
0.537
Gnomad4 EAS exome
AF:
0.404
Gnomad4 SAS exome
AF:
0.652
Gnomad4 FIN exome
AF:
0.676
Gnomad4 NFE exome
AF:
0.659
Gnomad4 OTH exome
AF:
0.615
GnomAD4 genome
AF:
0.585
AC:
88886
AN:
152060
Hom.:
26789
Cov.:
34
AF XY:
0.584
AC XY:
43398
AN XY:
74312
show subpopulations
Gnomad4 AFR
AF:
0.447
Gnomad4 AMR
AF:
0.597
Gnomad4 ASJ
AF:
0.530
Gnomad4 EAS
AF:
0.445
Gnomad4 SAS
AF:
0.639
Gnomad4 FIN
AF:
0.679
Gnomad4 NFE
AF:
0.659
Gnomad4 OTH
AF:
0.571
Alfa
AF:
0.641
Hom.:
31904
Bravo
AF:
0.568
Asia WGS
AF:
0.522
AC:
1818
AN:
3478
EpiCase
AF:
0.648
EpiControl
AF:
0.660

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Benign, no assertion criteria providedclinical testingDiagnostic Laboratory, Department of Genetics, University Medical Center Groningen-- -
Benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Congenital stationary night blindness autosomal dominant 2 Benign:2
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabJul 14, 2021- -
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Retinitis pigmentosa Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Retinitis pigmentosa 40 Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabJul 14, 2021- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
0.31
DANN
Benign
0.64

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs28675771; hg19: chr4-663908; COSMIC: COSV55324901; COSMIC: COSV55324901; API